Kevin Fitzgerald - Oct 6, 2021 Form 3 Insider Report for Ovid Therapeutics Inc. (OVID)

Role
Director
Signature
/s/ Danielle Mann for Kevin Joseph Fitzgerald by PoA
Stock symbol
OVID
Transactions as of
Oct 6, 2021
Transactions value $
$0
Form type
3
Date filed
10/7/2021, 04:27 PM
Next filing
Feb 4, 2022

No securities are beneficially owned.